Kilitch Drugs (India) Limited (NSE:KILITCH)
India · Delayed Price · Currency is INR 139.00
+0.65 (0.47%)
Apr 2, 2026, 3:29 PM IST
Kilitch Drugs (India) Market Cap
Kilitch Drugs (India) has a market cap or net worth of 4.86 billion as of April 2, 2026. Its market cap has decreased by -1.45% in one year.
Market Cap
4.86B
Enterprise Value
4.81B
Revenue
2.07B
Ranking
n/a
PE Ratio
18.38
Stock Price
139.00
Market Cap Chart
Since March 5, 2002, Kilitch Drugs (India)'s market cap has increased from 14.33M to 4.86B, an increase of 33,794.56%. That is a compound annual growth rate of 27.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 4.86B | -13.90% |
| Dec 31, 2025 | 5.64B | 7.84% |
| Dec 31, 2024 | 5.23B | -12.48% |
| Dec 29, 2023 | 5.98B | 145.95% |
| Dec 30, 2022 | 2.43B | -37.79% |
| Dec 31, 2021 | 3.91B | 162.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Windlas Biotech | 15.53B |
| Indoco Remedies | 15.14B |
| Jagsonpal Pharmaceuticals | 12.32B |
| Beta Drugs | 12.01B |
| Ind-Swift Laboratories | 11.40B |
| Sakar Healthcare | 11.09B |
| Sigachi Industries | 6.47B |
| Valiant Laboratories | 2.80B |